Načítá se...
JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines
BACKGROUND: JAK2V617F, a gain-of-function mutant form of tyrosine kinase JAK2, is found in the majority of patients with Ph- myeloproliferative neoplasms (MPNs), a group of chronic hematological diseases that often lead to acute leukemia. The current study is intended to find other gene mutations th...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3514099/ https://ncbi.nlm.nih.gov/pubmed/23210734 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2162-3619-1-15 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|